Demographics, Smell Test, and Cognitive Test Can Predict Cognitive Decline, Dementia
By Lori Solomon HealthDay Reporter
MONDAY, Oct. 21, 2024 -- Impairment in both an odor identification test and global cognition is comparable to positron emission tomography (PET) with 11C-Pittsburgh compound B (11C-PiB) for predicting cognitive decline and dementia, according to a study published online Oct. 10 in Alzheimer’s & Dementia.
Davangere P. Devanand, M.D., from Columbia University in New York City, and colleagues evaluated impaired odor identification and global cognition as simple, cost-effective alternatives to neuroimaging biomarkers to predict cognitive decline and dementia. The analysis included 647 participants in the Mayo Clinic Study of Aging, followed for a mean 8.1 years.
The researchers found that in survival analyses, PiB PET showed robust prediction for cognitive decline. Other significant predictors included an impaired 12-item Brief Smell Identification Test (BSIT), impaired modified Blessed Information Memory Concentration Test (BIMCT), magnetic resonance imaging results, and fluorodeoxyglucose measures. Strong predictive utility was seen with the combination of demographics, BSIT, and BIMCT (C-index, 0.81), which was similar to the combination of demographics and PiB PET (C-index, 0.80). Even stronger results were seen for prediction of dementia.
"Our study highlights a practical and cost-effective approach for predicting cognitive decline and dementia, which could greatly improve access to early diagnosis," Devanand said in a statement. "By using these simple tests, health care providers can gain additional clues for identifying those at risk, providing timely interventions, and increasing participation in clinical trials."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-10-22 06:00
Read more
- Big Post-Election Surge Seen in Online Sales of Morning-After Pills
- What You Need to Know About FluMist, the Nasal Flu Vaccine
- Lexicon Announces Outcome of FDA Advisory Committee for Zynquista (sotagliflozin) as an Adjunct to Insulin Therapy for Glycemic Control in Adults with Type 1 Diabetes and Chronic Kidney Disease
- AHA: Obesity-Linked Ischemic Heart Disease Mortality Increasing in U.S.
- UroGen Announces FDA Acceptance of its New Drug Application for UGN-102
- RSV Vaccination Prevents Associated Hospitalization, Emergency Encounters
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions